Regeneron Pharmaceuticals (REGN)
EBITDA
$5.75B
TTM · Period ending: · USD
REGN EBITDA
Latest reported$5.75Bperiod ending
Latest reported$5.75Bperiod ending
REGN EBITDA (-$3.00M → $5.75B)
Annual EBITDA
High-resolution chart · PNG
REGN ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 5,818,200,000 | |
| 5,318,000,000 | |
| 4,693,300,000 | |
| 5,259,600,000 | |
| 9,669,300,000 | |
| 4,103,200,000 | |
| 2,669,600,000 | |
| 2,729,900,000 | |
| 2,249,097,000 | |
| 1,441,755,000 | |
| 1,314,247,000 | |
| 865,805,000 | |
| 801,001,000 | |
| 496,665,000 | |
| -170,528,000 | |
| -75,663,000 | |
| -55,368,000 | |
| -61,320,000 | |
| -82,070,000 | |
| -76,515,000 | |
| -67,896,000 | |
| 69,236,000 | |
| -91,513,000 | |
| -113,499,000 | |
| -79,606,000 | |
| -20,855,000 | |
| -20,400,000 | |
| -9,500,000 | |
| -9,300,000 | |
| -11,200,000 | |
| -1,700,000 | |
| -25,000,000 | |
| -35,700,000 | |
| -16,300,000 | |
| -8,800,000 | |
| -3,000,000 |